Post-COVID syndrome
DOI:
https://doi.org/10.14739/2310-1210.2022.6.252741Keywords:
post-acute COVID-19 syndrome, pneumonia, SARS-CoV-2, outpatient careAbstract
The aim is to study the frequency and symptoms of post-COVID syndrome in patients with pneumonia caused by SARS-CoV-2, who were treated in an outpatient setting.
Materials and methods. Personal monitoring results of the health state of 62 patients who suffered pneumonia caused by the SARS-CoV-2 and were treated in the outpatient setting between May 2020 and September 2021 were analyzed. The patients were divided into 3 clinical groups depending on age, concomitant diseases, and extent of the process in the lungs. The examination results were processed on a personal computer using the statistical package Statistica program, version 10.
Results. The prevalence of post-COVID syndrome with the symptoms that characterize it is significantly higher in patients who have not been vaccinated with the COVID-19 vaccine, who have suffered pneumonia caused by SARS-CoV-2 of a moderate-to-severe course with the process extent in the lungs from 25 % to 50 %, with its repeated cases, regardless of age and the presence of concomitant pathologies. Prolonged COVID-19 (early post-COVID syndrome) and post-COVID syndrome are main complications of COVID-19 with the most common symptoms such as general fatigue, depression, impaired memory concentration, sleep disorder, myalgia/arthralgia.
Conclusions. Even a mild course of pneumonia caused by SARS-CoV-2 is accompanied by post-COVID syndrome, which requires long-term supervision and practice of rehabilitation techniques for such patients. Treatment of pneumonia caused by the SARS-CoV-2 with the moderate-to-severe course in outpatient conditions leads to an increase in the frequency and severity of the post-COVID syndrome course. Vaccination with a vaccine against COVID-19 to prevent the development of a severe course of pneumonia caused by the SARS-CoV-2 remains an urgent issue. Identified dental manifestations (stomatitis, periodontitis, and periodontal disease) should be considered by dentists in the early period of post-COVID syndrome, and dental pathology examination should be continued during the treatment of pneumonia caused by SARS-CoV-2 in post-COVID syndrome.
References
Rekalova O. M. (2020). COVID-19 – nova virusna infektsiia: patohenez, diahnostyka, likuvannia [COVID-19 – a new viral infection: pathogenesis, diagnosis, treatment]. Tuberkuloz, lehenevi khvoroby, VIL-infektsiia, (2), 7-9. [in Ukrainian]. https://doi.org/10.30978/TB2020-2-7
WHO. (2021). Coronavirus (COVID-19) Dashboard (Ukraine). https://covid19.who.int/region/euro/country/ua
McIntosh, K. (2022). Covid-19: Epidemiology, virology, and prevention. Update, 1-80. https://www.uptodate.com/contents/covid-19-epidemiology-virology-and-prevention
Zhou, P., Yang, X. L., Wang, X. G., Hu, B., Zhang, L., Zhang, W., Si, H. R., Zhu, Y., Li, B., Huang, C. L., Chen, H. D., Chen, J., Luo, Y., Guo, H., Jiang, R. D., Liu, M. Q., Chen, Y., Shen, X. R., Wang, X., Zheng, X. S., … Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-273. https://doi.org/10.1038/s41586-020-2012-7
Zou, X., Chen, K., Zou, J., Han, P., Hao, J., & Han, Z. (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Frontiers of medicine, 14(2), 185-192. https://doi.org/10.1007/s11684-020-0754-0
Wadman, M., Couzin-Frankel, J., Kaiser, J., & Matacic, C. (2020). A rampage through the body. Science, 368(6489), 356-360. https://doi.org/10.1126/science.368.6489.356
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020). The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European journal of internal medicine, 76, 14-20. https://doi.org/10.1016/j.ejim.2020.04.037
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., Freedberg, D. E., Kirtane, A. J., Parikh, S. A., Maurer, M. S., Nordvig, A. S., Accili, D., Bathon, J. M., Mohan, S., Bauer, K. A., Leon, M. B., … Landry, D. W. (2020). Extrapulmonary manifestations of COVID-19. Nature medicine, 26(7), 1017-1032. https://doi.org/10.1038/s41591-020-0968-3
Ministry of Health of Ukraine. (2014, September 17). Pro vnesennia zmin do Standartiv medychnoi dopomogy [On amendments to the Standards of medical care "Coronavirus disease (COVID-19) (No. 2122)]. https://moz.gov.ua/article/ministry-mandates/nakaz-moz-ukraini-vid-17092020--2122pro-vnesennja-zmin-do-standartiv-medichnoi-dopomogi-koronavirusna-hvoroba-covid-19
Yin, X., Xu, X., Li, H., Jiang, N., Wang, J., Lu, Z., Xiong, N., & Gong, Y. (2022). Evaluation of early antibiotic use in patients with non-severe COVID-19 without bacterial infection. International journal of antimicrobial agents, 59(1), 106462. https://doi.org/10.1016/j.ijantimicag.2021.106462
Hyts, A R. (2021). COVID-19: sprostovana efektyvnist antybiotykoterapii [COVID-19: refuted effectiveness of antibiotic therapy]. Ukrainskiy medychnyi chasopys. [in Ukrainian]. https://www.umj.com.ua/article/199629/covid-19-sprostovana-efektivnist-antibiotikoterapiyi
Bouteleux, B., Henrot, P., Ernst, R., Grassion, L., Raherison-Semjen, C., Beaufils, F., Zysman, M., & Delorme, M. (2021). Respiratory rehabilitation for Covid-19 related persistent dyspnoea: A one-year experience. Respiratory medicine, 189, 106648. https://doi.org/10.1016/j.rmed.2021.106648
Buttery, S., Philip, K., Williams, P., Fallas, A., West, B., Cumella, A., Cheung, C., Walker, S., Quint, J. K., Polkey, M. I., & Hopkinson, N. S. (2021). Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ open respiratory research, 8(1), e001075. https://doi.org/10.1136/bmjresp-2021-001075
Darley, D. R., Dore, G. J., Cysique, L., Wilhelm, K. A., Andresen, D., Tonga, K., Stone, E., Byrne, A., Plit, M., Masters, J., Tang, H., Brew, B., Cunningham, P., Kelleher, A., & Matthews, G. V. (2021). Persistent symptoms up to four months after community and hospital-managed SARS-CoV-2 infection. The Medical journal of Australia, 214(6), 279-280. https://doi.org/10.5694/mja2.50963
Lerum, T. V., Aaløkken, T. M., Brønstad, E., Aarli, B., Ikdahl, E., Lund, K., Durheim, M. T., Rodriguez, J. R., Meltzer, C., Tonby, K., Stavem, K., Skjønsberg, O. H., Ashraf, H., & Einvik, G. (2021). Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. The European respiratory journal, 57(4), 2003448. https://doi.org/10.1183/13993003.03448-2020
Griffiths, J., Hatch, R. A., Bishop, J., Morgan, K., Jenkinson, C., Cuthbertson, B. H., & Brett, S. J. (2013). An exploration of social and economic outcome and associated health-related quality of life after critical illness in general intensive care unit survivors: a 12-month follow-up study. Critical care, 17(3), R100. https://doi.org/10.1186/cc12745
Davidson, J. E., Jones, C., & Bienvenu, O. J. (2012). Family response to critical illness: postintensive care syndrome-family. Critical care medicine, 40(2), 618-624. https://doi.org/10.1097/CCM.0b013e318236ebf9
Cortinovis M., Perico N. & Remuzzi G. (2021). Long-term follow-up of recovered patients with COVID-19. Lancet, 397(10270), 173-175. https://doi.org/10.1016/S0140-6736(21)00039-8
Moreno-Pérez, O., Merino, E., Leon-Ramirez, J. M., Andres, M., Ramos, J. M., Arenas-Jiménez, J., Asensio, S., Sanchez, R., Ruiz-Torregrosa, P., Galan, I., Scholz, A., Amo, A., González-delaAleja, P., Boix, V., Gil, J., & COVID19-ALC research group (2021). Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. The Journal of infection, 82(3), 378-383. https://doi.org/10.1016/j.jinf.2021.01.004
Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., Smithline, H. A., Gong, M. N., Aboodi, M. S., Exline, M. C., Henning, D. J., Wilson, J. G., Khan, A., Qadir, N., Brown, S. M., Peltan, I. D., Rice, T. W., … IVY Network Investigators (2020). Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR. Morbidity and mortality weekly report, 69(30), 993-998. https://doi.org/10.15585/mmwr.mm6930e1
Carvalho-Schneider, C., Laurent, E., Lemaignen, A., Beaufils, E., Bourbao-Tournois, C., Laribi, S., Flament, T., Ferreira-Maldent, N., Bruyère, F., Stefic, K., Gaudy-Graffin, C., Grammatico-Guillon, L., & Bernard, L. (2021). Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical microbiology and infection, 27(2), 258-263. https://doi.org/10.1016/j.cmi.2020.09.052
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
